Genprex (GNPX) Earnings Analysis

Genprex (GNPX) has no confirmed upcoming earnings date. Last quarter (2026-03-27) it beat with EPS -1.15 USD vs -286 USD est (+99.6%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E -0.03.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does GNPX next report earnings?

No confirmed upcoming earnings date is currently scheduled for GNPX. This page updates as the calendar is published.

GNPX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-27-1.15 USD-286 USD+99.6%Beat
2025-11-14-5 USD-12.5 USD+60%Beat
2025-08-08-8.5 USD-15.62 USD+45.6%Beat
2025-05-21-13 USD-18.04 USD+27.9%Beat
2025-04-01-21 USD-18.04 USD-16.4%Miss
2024-08-19-150 USD-50.6 USD-196.4%Miss

Beat rate: 4/6 (67%) over reported quarters with consensus data.

GNPX valuation and analyst view

Trailing P/E-0.03
Trailing EPS-52.93116 USD
Price / book0.16
Dividend yield0.00%
Market cap0.00B
Analyst consensusBuy (1 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is Genprex (GNPX)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for GNPX. This page updates as the calendar is published.

Did GNPX beat earnings last quarter?

In its 2026-03-27 report, GNPX posted EPS of -1.15 USD versus a -286 USD estimate — a beat of 99.6%.

What is GNPX's earnings track record?

Over the last 6 reported quarters with consensus data, GNPX beat estimates 4 times (67%).

What is GNPX's current P/E ratio and EPS?

GNPX trades at a trailing P/E of -0.03 on trailing EPS of -52.931161392405066 USD.

What do analysts rate GNPX?

Analyst consensus is "Buy" across 1 ratings (0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell).